Cargando…
Letter to the Editor: There Is No Indication for Treating Long COVID Vaccination Syndrome With Colchicine
Autor principal: | Finsterer, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792258/ https://www.ncbi.nlm.nih.gov/pubmed/36573390 http://dx.doi.org/10.3346/jkms.2022.37.e357 |
Ejemplares similares
-
Letter to the Editor: Propacetamol-Induced Rhabdomyolysis or COVID-Vaccine-Related Inflammatory Myopathy?
por: Finsterer, Josef
Publicado: (2022) -
Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome
por: Finsterer, Josef
Publicado: (2022) -
Letter to the Editor: Ischemic Stroke of the Corpus Callosum after SARS-CoV-2 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2021) -
Letter to the Editor: Rule Out Alternative Mechanisms Before Attributing Elevated Hemidiaphragm to Parsonage Turner Syndrome and SARS-CoV-2 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022) -
Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Finsterer, Josef
Publicado: (2022)